{"entity":{"type":"insider","cik":"0001868997","url":"/insider/0001868997","json_url":"/insider/0001868997.json","name":"Gillies Hunter","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":15,"first":"2023-04-25","last":"2024-06-14","span_basis":"filed_date"},"name_variants":[{"name":"Gillies Hunter","source":"filing","n_filings":15,"first_seen":"2023-04-25","last_seen":"2024-06-14"}],"transactions":[{"id":3262834,"accession":"0001415889-24-016993","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-016993","line_url":"/filing/0001415889-24-016993#line-2","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":24.5,"price_display":"24.50","price_state":"stated","total_value":147000.0,"total_display":"147,000.00","total_whole":"147,000","shares_owned_after":5602.0,"shares_owned_after_display":"5,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-13","filed_date":"2024-06-14","scope":"insider"},{"id":2953331,"accession":"0001415889-24-013630","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-013630","line_url":"/filing/0001415889-24-013630","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":21.0828753,"price_display":"21.08","price_state":"stated","total_value":84331.5012,"total_display":"84,331.50","total_whole":"84,332","shares_owned_after":5688.0,"shares_owned_after_display":"5,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-17","filed_date":"2024-05-17","scope":"insider","n_lines":2},{"id":3141454,"accession":"0001415889-24-011251","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-011251","line_url":"/filing/0001415889-24-011251","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":22.380457025,"price_display":"22.38","price_state":"stated","total_value":89521.8281,"total_display":"89,521.83","total_whole":"89,522","shares_owned_after":3562.0,"shares_owned_after_display":"3,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-17","filed_date":"2024-04-19","scope":"insider","n_lines":2},{"id":2255930,"accession":"0001415889-24-009596","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-009596","line_url":"/filing/0001415889-24-009596#line-2","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":29.5,"price_display":"29.50","price_state":"stated","total_value":265500.0,"total_display":"265,500.00","total_whole":"265,500","shares_owned_after":3251.0,"shares_owned_after_display":"3,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-28","filed_date":"2024-04-01","scope":"insider"},{"id":2222005,"accession":"0001415889-24-008771","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-008771","line_url":"/filing/0001415889-24-008771","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":25.865235785714287,"price_display":"25.87","price_state":"stated","total_value":181056.6505,"total_display":"181,056.65","total_whole":"181,057","shares_owned_after":3864.0,"shares_owned_after_display":"3,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-18","filed_date":"2024-03-20","scope":"insider","n_lines":2},{"id":2155483,"accession":"0001415889-24-007533","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-007533","line_url":"/filing/0001415889-24-007533#line-2","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8975.0,"shares_display":"8,975","price_per_share":24.5,"price_display":"24.50","price_state":"stated","total_value":219887.5,"total_display":"219,887.50","total_whole":"219,888","shares_owned_after":3251.0,"shares_owned_after_display":"3,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":2369156,"accession":"0001415889-24-005571","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-005571","line_url":"/filing/0001415889-24-005571#line-2","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":511.0,"shares_display":"511","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":9964.5,"total_display":"9,964.50","total_whole":"9,965","shares_owned_after":3251.0,"shares_owned_after_display":"3,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-23","filed_date":"2024-02-27","scope":"insider"},{"id":2484044,"accession":"0001415889-24-004903","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-004903","line_url":"/filing/0001415889-24-004903","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3489.0,"shares_display":"3,489","price_per_share":20.22771728288908,"price_display":"20.23","price_state":"stated","total_value":70574.5056,"total_display":"70,574.51","total_whole":"70,575","shares_owned_after":4149.0,"shares_owned_after_display":"4,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-22","scope":"insider","n_lines":2},{"id":2154941,"accession":"0001415889-24-001609","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-001609","line_url":"/filing/0001415889-24-001609#line-2","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":78000.0,"total_display":"78,000.00","total_whole":"78,000","shares_owned_after":3251.0,"shares_owned_after_display":"3,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-19","scope":"insider"},{"id":8035925,"accession":"0001415889-23-017025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-017025","line_url":"/filing/0001415889-23-017025#line-2","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125.0,"shares_display":"125","price_per_share":24.5,"price_display":"24.50","price_state":"stated","total_value":3062.5,"total_display":"3,062.50","total_whole":"3,063","shares_owned_after":3251.0,"shares_owned_after_display":"3,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-27","filed_date":"2023-12-29","scope":"insider"},{"id":8517426,"accession":"0001415889-23-016908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-016908","line_url":"/filing/0001415889-23-016908#line-2","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":78000.0,"total_display":"78,000.00","total_whole":"78,000","shares_owned_after":3251.0,"shares_owned_after_display":"3,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-22","scope":"insider"},{"id":8035906,"accession":"0001415889-23-016539","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-23-016539","line_url":"/filing/0001415889-23-016539#line-4","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9897.0,"shares_display":"9,897","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":192991.5,"total_display":"192,991.50","total_whole":"192,992","shares_owned_after":3251.0,"shares_owned_after_display":"3,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-15","scope":"insider"},{"id":8035902,"accession":"0001415889-23-016539","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-016539","line_url":"/filing/0001415889-23-016539#line-2","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2103.0,"shares_display":"2,103","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":41008.5,"total_display":"41,008.50","total_whole":"41,009","shares_owned_after":3251.0,"shares_owned_after_display":"3,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-15","scope":"insider"},{"id":7958680,"accession":"0001415889-23-008658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-008658","line_url":"/filing/0001415889-23-008658#line-2","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65.0,"shares_display":"65","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":1267.5,"total_display":"1,267.50","total_whole":"1,268","shares_owned_after":3251.0,"shares_owned_after_display":"3,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-19","filed_date":"2023-05-23","scope":"insider"},{"id":8304620,"accession":"0001415889-23-008425","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-008425","line_url":"/filing/0001415889-23-008425#line-2","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1090.0,"shares_display":"1,090","price_per_share":19.5925,"price_display":"19.59","price_state":"stated","total_value":21355.825,"total_display":"21,355.82","total_whole":"21,356","shares_owned_after":3251.0,"shares_owned_after_display":"3,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-19","scope":"insider"},{"id":7929924,"accession":"0001415889-23-006838","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-006838","line_url":"/filing/0001415889-23-006838#line-2","is_derivative":false,"issuer_cik":"0001798749","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001798749","owner_cik":"0001868997","owner_name":"Gillies Hunter","owner_display_name":"Gillies Hunter","owner_url":"/insider/0001868997","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":78000.0,"total_display":"78,000.00","total_whole":"78,000","shares_owned_after":1960.0,"shares_owned_after_display":"1,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-21","filed_date":"2023-04-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001798749","name":"Aerovate Therapeutics, Inc.","url":"/issuer/0001798749","role":"Officer (CHIEF MEDICAL OFFICER)","n_filings":15,"first_seen":"2023-04-25","last_seen":"2024-06-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001868997","retrieved_at":"2026-08-25T15:08:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}